Expanded Carrier Screening: A General Overview
Genetic disorders previously associated with specific ethnic groups now occur at increasing frequency in broader populations. Based on assumptions about prevalence, traditional carrier screening only targets single gene disorders according to ancestry or family history and may not accurately reflect changing frequencies. Expanded carrier screening (ECS) by next-generation sequencing (NGS) enables rapid carrier screening research and genetic analysis across a broader range of disorders, crossing ancestries and geographic regions with an accurate, scalable, cost-effective solution.
This on-demand webinar from Thermo Fisher Scientific reviews the benefits of ECS, presents Mayo Clinic case studies illustrating the capabilities and complexities of ECS, and discusses guidelines to consider in developing ECS content.